SysteMHC v.231201
Home Datasets Download Help About Update

Showing details for project SYSMHC00033



SampleID NumReplicates Organism TissueType CellType MHCAllele
SampleID NumReplicates Organism TissueType CellType MHCAllele
SYSMHC00033_20160513_TIL1 2 Human HLA-A02_01,HLA-B18_01,HLA-B38_01,HLA-C05_01
SYSMHC00033_20160513_TIL2 2 Human no allele
SYSMHC00033_20160513_TIL3 2 Human HLA-A01_01,HLA-A23_01,HLA-B07_02,HLA-B15_01,HLA-C12_03,HLA-C14_02
SYSMHC00033_20160513_TIL4 2 Human no allele
SYSMHC00033_20160517_DC 5 Human no allele
SYSMHC00033_20160517_GD149 5 Human HLA-A01_01,HLA-A24_02,HLA-B38_01,HLA-B44_03,HLA-C06_02,HLA-C12_03
SYSMHC00033_Apher-1 2 Human HLA-A03_01,HLA-A29_02,HLA-B44_02,HLA-B44_03,HLA-C12_03,HLA-C16_01
SYSMHC00033_Apher-6 2 Human HLA-A02_01,HLA-A03_01,HLA-B07_02,HLA-C07_02
SYSMHC00033_CM647_MG 2 Human HLA-A01_01,HLA-A24_02,HLA-B13_02,HLA-B39_06,HLA-C06_02,HLA-C12_03
SYSMHC00033_CM647_NG 2 Human HLA-A01_01,HLA-A24_02,HLA-B13_02,HLA-B39_06,HLA-C06_02,HLA-C12_03
SYSMHC00033_HLApI_TIL3 3 Human HLA-A01_01,HLA-A23_01,HLA-B07_02,HLA-B15_01,HLA-C12_03,HLA-C14_02
SYSMHC00033_HLApI_pooledTIL3 3 Human HLA-A01_01,HLA-A23_01,HLA-B07_02,HLA-B15_01,HLA-C12_03,HLA-C14_02
SYSMHC00033_MD155 3 Human HLA-A02_01,HLA-A24_02,HLA-B15_01,HLA-B18_01,HLA-C03_03,HLA-C07_01
SYSMHC00033_PD42 2 Human HLA-A02_06,HLA-A24_02,HLA-B07_02,HLA-B55_01,HLA-C01_02,HLA-C07_02
SYSMHC00033_RA957_MG 2 Human HLA-A02_20,HLA-A68_01,HLA-B35_03,HLA-B39_01,HLA-C04_01,HLA-C07_02
SYSMHC00033_RA957_NG 2 Human HLA-A02_20,HLA-A68_01,HLA-B35_03,HLA-B39_01,HLA-C04_01,HLA-C07_02



Detailed view of sample SYSMHC00033_PD42



ID SampleID RawFileName Organism Process Tissue Type Cell Type Culture Conditions Disease State Comments MHCClass MHCAllele PubMed ID Peptide Isolation Method Antibody Mass Spectrometer LC System iRT Peptides Acquisition Mode Fragmentation Method Gradient Gradient Length Flow Rate Replicate Number
ID SampleID RawFileName Organism Process Tissue_Type Cell_Type Culture_Conditions Disease_State Comments MHCClass MHCAllele PubMed_ID Peptide Isolation_Method Antibody Mass_Spectrometer LC_System iRT_Peptides Acquisition_Mode Fragmentation_Method Gradient Gradient_Length Flow_Rate Replicate_Number
SYSMHC00033 SYSMHC00033_PD42 20160617_PD42_w6_S1_R1.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02_06,HLA-A24_02,HLA-B07_02,HLA-B55_01,HLA-C01_02,HLA-C07_02 28832583 native Immunoaffinity W6/32 Orbitrap Fusion Lumos Dionex Ultimate RSLC3000 nanoLC no DDA HCD 1
SYSMHC00033 SYSMHC00033_PD42 20160617_PD42_w6_S3_R1.raw Human In vitro Blood Lymphoblast cell suspension EBV transformed class I HLA-A02_06,HLA-A24_02,HLA-B07_02,HLA-B55_01,HLA-C01_02,HLA-C07_02 28832583 native Immunoaffinity W6/32 Orbitrap Fusion Lumos Dionex Ultimate RSLC3001 nanoLC no DDA HCD 2